GAINZ

GLADSTONE INVESTMENT CORPORATION\DE

Nasdaq · CIK 0001321741
$24.00 -0.51% $917.3M
Vol
Market Cap$917.3M
Cap SizeSmall Cap
Reddit Sentiment55° Neutral
Exchange Nasdaq·CIK 0001321741·Prev Close $24.12

Analyst Ratings

Historical distribution82% buy · 11 analysts · no recent coverage
3Strong Buy
6Buy
2Hold
0Sell
0Strong Sell

Reddit Sentiment

55°
Neutral
Bearish Neutral Bullish
7 mentions 1 bullish 0 bearish

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution: 82% buy across 11 analysts — 3 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20263620082%
May 1, 20263530073%
Apr 1, 20263530073%
Mar 1, 20263530073%
Feb 1, 20263540067%
Jan 1, 20263540067%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

55°
Neutral
Bearish Neutral Bullish
7 mentions 1 bullish 0 bearish 7 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
May 31, 2026150° Neutral001
May 31, 2026150° Neutral001
May 14, 2026150° Neutral001
May 14, 2026150° Neutral001
Apr 14, 2026150° Neutral001
Apr 14, 2026150° Neutral001
Feb 24, 2026160° Warm101

Recent Reddit Threads

r/wallstreetbets Neutral 6d 8h ago
$Dell GAINZ
▲ 1 💬 0 ⚡ 0.5
r/wallstreetbets Neutral 1mo ago
Go-Pro GAINZ
▲ 1 💬 1 ⚡ 0.5
r/wallstreetbets Neutral 23d 22h ago
NOK GAINZ - closing tmrw
▲ 1 💬 1 ⚡ 0.5
r/wallstreetbets Bullish 3mo ago
IOVA GAINZ 🚀🚀🚀
▲ 1 💬 1 ⚡ 0.0

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.